![]() |
search:
|
| contact us |
|
|
Extensively Drug Resistant TB - June 1, 2007The following is information regarding the current extensively drug-resistant tuberculosis (XDR-TB) situation. If you have any questions on these or other clinical issues, please write to us at coca@cdc.gov. XDR TBThe following documents have been recently posted or updated:
The CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Links to non-Federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organizations. Please send us your feedback or comments: http://www.cdc.gov/flu/coca/feedback.htm. Our Clinician Communication Team is committed to excellence in reporting our weekly updates. Please e-mail coca@cdc.gov should you note any written errors or discrepancies. If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry. If you need further information or technical help, please send an e-mail message to: coca@cdc.gov.
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|